Candel Therapeutics, Inc.

NASDAQ:CADL

4.98 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 102.65416.55821.45425.71335.41342.98351.89459.25870.05877.18386.78294.32182.64288.38524.31629.15235.053-45.057
Short Term Investments 0000000000000000090.114
Cash and Short Term Investments 102.65416.55821.45425.71335.41342.98351.89459.25870.05877.18386.78294.32182.64288.38524.31629.15235.05345.057
Net Receivables 000000000000000000
Inventory 000000000000000000
Other Current Assets 1.151.5271.2811.4231.3842.1181.4682.6171.8873.7741.0882.654.6065.130.220.3190.0930
Total Current Assets 103.80418.08522.73527.13636.79745.10153.36261.87571.94579.0787.32695.64684.94590.9524.42629.47135.14645.057
Non-Current Assets:
Property, Plant & Equipment, Net 2.7333.0913.4033.7134.0224.5554.9215.0975.485.6715.7095.4793.8364.5874.6064.2632.7870
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 00000000-1.094000000000
Long Term Investments 0000.2660.2660.2660.26600.2660.2660.2660.4370.4240.42300.42300
Tax Assets 00000.5010000.828000000000
Other Non-Current Assets 0.3290.3410.3470.1020.1160.1390.1590.2660.266000001.7120.9370.349-45.057
Total Non-Current Assets 3.0623.4323.754.0814.9054.965.3465.3635.7465.9375.9755.9164.265.016.3185.6233.136-45.057
Total Assets 106.86621.51726.48531.21741.70250.06158.70867.23877.69185.00793.301101.56289.20595.9630.74435.09438.2820
Liabilities & Equity:
Current Liabilities:
Account Payables 0.2370.2960.4330.4720.4220.250.480.5920.380.971.5841.3861.590.9250.7591.5130.9210
Short Term Debt 10.46110.40310.88710.2939.9197.14.141.7290.9280.9040.880.8580000.4640.4630
Tax Payables 000000000000000000
Deferred Revenue 000000.1080.1200.14400000.0310.0633.2983.1420
Other Current Liabilities 26.8314.5692.6762.7723.8432.9773.5432.9154.3074.0243.4143.2283.7723.4723.7353.5213.3290
Total Current Liabilities 37.52915.26813.99613.53714.18410.3278.1635.2365.6155.8985.8785.4725.3624.3974.4945.4984.7130
Non-Current Liabilities:
Long Term Debt 3.015.628.21310.79213.35616.17118.6421.0622.33622.35622.35522.3630.560.5410.5210.5020.4830
Deferred Revenue Non-Current 00000.9730.1080.120.1320.14400000.0310.0630.0940.1250
Deferred Tax Liabilities Non-Current 00000.501-14.447-16.82300.828000000000
Other Non-Current Liabilities 015.88614.2480.9090.9160.5411.1341.1581.8824.6264.9969.96519.14628.00419.78156.49756.5230
Total Non-Current Liabilities 3.0121.50622.46111.70114.77316.71219.77422.3524.36226.98227.35132.32819.70628.57669.42557.09357.1310
Total Liabilities 40.53936.77436.45725.23828.95727.03927.93727.58629.97732.8833.22937.825.06832.97373.91962.59161.8440
Equity:
Preferred Stock 000000000000095.9626.5649.0649.0649.06
Common Stock 0.4690.3220.3030.2920.290.290.290.290.290.290.290.2870.2860.2860.1170.1170.1160
Retained Earnings -192.205-178.132-167.486-145.249-137.028-125.933-117.498-107.884-99.089-94.006-85.318-81.169-80.295-81.891-65.729-48.649-44.1710
Accumulated Other Comprehensive Income/Loss 0000-0000-000-00-95.96-26.56-0.16-49.06-8.038
Other Total Stockholders Equity 258.063162.553157.211150.936149.483148.665147.979147.246146.513145.843145.1144.644144.14648.63271.49721.19569.5530
Total Shareholders Equity 66.327-15.257-9.9725.97912.74523.02230.77139.652-99.08952.12760.07263.76264.13762.987-43.175-27.497-23.56241.022
Total Equity 66.327-15.257-9.9725.97912.74523.02230.77139.652-99.08952.12760.07263.76264.13762.987-43.175-27.497-23.56241.022
Total Liabilities & Shareholders Equity 106.86621.51726.48531.21741.70250.06158.70867.238-69.11285.00793.301101.56289.20595.9630.74435.09438.28241.022